Selected research
Industry Research
Nonspecific Endonuclease Industry Research Report 2026
Market perspective
The global Nonspecific Endonuclease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nonspecific Endonuclease market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nonspecific Endonuclease market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nonspecific Endonuclease market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nonspecific Endonuclease include Yisheng Biotechnology (Shanghai) Co., Ltd., Shanghai Zhudian Biotechnology Co., Ltd., Thermo Fisher Scientific Inc., KACTUS, GenScript, Shanghai Biyuntian Biotechnology Co., Ltd., TransGen Biotech, RayBiotech, Inc. and ACROBiosystems Group and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nonspecific Endonuclease market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nonspecific Endonuclease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nonspecific Endonuclease Market by Company
Yisheng Biotechnology (Shanghai) Co., Ltd.
Shanghai Zhudian Biotechnology Co., Ltd.
Thermo Fisher Scientific Inc.
KACTUS
GenScript
Shanghai Biyuntian Biotechnology Co., Ltd.
TransGen Biotech
RayBiotech, Inc.
ACROBiosystems Group
AbMole BioScience
Nonspecific Endonuclease Segment by Type
100kU
25kU
50kU
5kU
＞100kU
Nonspecific Endonuclease Segment by Application
Biological Laboratory
University Research Room
Others
Nonspecific Endonuclease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonspecific Endonuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nonspecific Endonuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonspecific Endonuclease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nonspecific Endonuclease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100kU
- 25kU
- 50kU
- 5kU
- ＞100kU
Applications
- Biological Laboratory
- University Research Room
- Others
Companies covered
- Yisheng Biotechnology (Shanghai) Co., Ltd.
- Shanghai Zhudian Biotechnology Co., Ltd.
- Thermo Fisher Scientific Inc.
- KACTUS
- GenScript
- Shanghai Biyuntian Biotechnology Co., Ltd.
- TransGen Biotech
- RayBiotech, Inc.
- ACROBiosystems Group
- AbMole BioScience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nonspecific Endonuclease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 100kU
- 2.2.3 25kU
- 2.2.4 50kU
- 2.2.5 5kU
- 2.2.6 ＞100kU
- 2.3 Nonspecific Endonuclease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biological Laboratory
- 2.3.3 University Research Room
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Nonspecific Endonuclease Breakdown Data by Type
- 3.1 Global Nonspecific Endonuclease Historic Market Size by Type (2021-2026)
- 3.2 Global Nonspecific Endonuclease Forecasted Market Size by Type (2027-2032)
4 Nonspecific Endonuclease Breakdown Data by Application
- 4.1 Global Nonspecific Endonuclease Historic Market Size by Application (2021-2026)
- 4.2 Global Nonspecific Endonuclease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nonspecific Endonuclease Market Perspective (2021-2032)
- 5.2 Global Nonspecific Endonuclease Growth Trends by Region
- 5.2.1 Global Nonspecific Endonuclease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nonspecific Endonuclease Historic Market Size by Region (2021-2026)
- 5.2.3 Nonspecific Endonuclease Forecasted Market Size by Region (2027-2032)
- 5.3 Nonspecific Endonuclease Market Dynamics
- 5.3.1 Nonspecific Endonuclease Industry Trends
- 5.3.2 Nonspecific Endonuclease Market Drivers
- 5.3.3 Nonspecific Endonuclease Market Challenges
- 5.3.4 Nonspecific Endonuclease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nonspecific Endonuclease Players by Revenue
- 6.1.1 Global Top Nonspecific Endonuclease Players by Revenue (2021-2026)
- 6.1.2 Global Nonspecific Endonuclease Revenue Market Share by Players (2021-2026)
- 6.2 Global Nonspecific Endonuclease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nonspecific Endonuclease Head Office and Area Served
- 6.4 Global Nonspecific Endonuclease Players, Product Type & Application
- 6.5 Global Nonspecific Endonuclease Manufacturers Established Date
- 6.6 Global Nonspecific Endonuclease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nonspecific Endonuclease Market Size (2021-2032)
- 7.2 North America Nonspecific Endonuclease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nonspecific Endonuclease Market Size by Country (2021-2026)
- 7.4 North America Nonspecific Endonuclease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nonspecific Endonuclease Market Size (2021-2032)
- 8.2 Europe Nonspecific Endonuclease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nonspecific Endonuclease Market Size by Country (2021-2026)
- 8.4 Europe Nonspecific Endonuclease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nonspecific Endonuclease Market Size (2021-2032)
- 9.2 Asia-Pacific Nonspecific Endonuclease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nonspecific Endonuclease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nonspecific Endonuclease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nonspecific Endonuclease Market Size (2021-2032)
- 10.2 South America Nonspecific Endonuclease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nonspecific Endonuclease Market Size by Country (2021-2026)
- 10.4 South America Nonspecific Endonuclease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nonspecific Endonuclease Market Size (2021-2032)
- 11.2 Middle East & Africa Nonspecific Endonuclease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nonspecific Endonuclease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nonspecific Endonuclease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Yisheng Biotechnology (Shanghai) Co., Ltd.
- 12.1.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
- 12.1.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
- 12.1.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.1.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Nonspecific Endonuclease Product Portfolio
- 12.1.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments
- 12.2 Shanghai Zhudian Biotechnology Co., Ltd.
- 12.2.1 Shanghai Zhudian Biotechnology Co., Ltd. Company Information
- 12.2.2 Shanghai Zhudian Biotechnology Co., Ltd. Business Overview
- 12.2.3 Shanghai Zhudian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.2.4 Shanghai Zhudian Biotechnology Co., Ltd. Nonspecific Endonuclease Product Portfolio
- 12.2.5 Shanghai Zhudian Biotechnology Co., Ltd. Recent Developments
- 12.3 Thermo Fisher Scientific Inc.
- 12.3.1 Thermo Fisher Scientific Inc. Company Information
- 12.3.2 Thermo Fisher Scientific Inc. Business Overview
- 12.3.3 Thermo Fisher Scientific Inc. Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific Inc. Nonspecific Endonuclease Product Portfolio
- 12.3.5 Thermo Fisher Scientific Inc. Recent Developments
- 12.4 KACTUS
- 12.4.1 KACTUS Company Information
- 12.4.2 KACTUS Business Overview
- 12.4.3 KACTUS Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.4.4 KACTUS Nonspecific Endonuclease Product Portfolio
- 12.4.5 KACTUS Recent Developments
- 12.5 GenScript
- 12.5.1 GenScript Company Information
- 12.5.2 GenScript Business Overview
- 12.5.3 GenScript Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.5.4 GenScript Nonspecific Endonuclease Product Portfolio
- 12.5.5 GenScript Recent Developments
- 12.6 Shanghai Biyuntian Biotechnology Co., Ltd.
- 12.6.1 Shanghai Biyuntian Biotechnology Co., Ltd. Company Information
- 12.6.2 Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview
- 12.6.3 Shanghai Biyuntian Biotechnology Co., Ltd. Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.6.4 Shanghai Biyuntian Biotechnology Co., Ltd. Nonspecific Endonuclease Product Portfolio
- 12.6.5 Shanghai Biyuntian Biotechnology Co., Ltd. Recent Developments
- 12.7 TransGen Biotech
- 12.7.1 TransGen Biotech Company Information
- 12.7.2 TransGen Biotech Business Overview
- 12.7.3 TransGen Biotech Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.7.4 TransGen Biotech Nonspecific Endonuclease Product Portfolio
- 12.7.5 TransGen Biotech Recent Developments
- 12.8 RayBiotech, Inc.
- 12.8.1 RayBiotech, Inc. Company Information
- 12.8.2 RayBiotech, Inc. Business Overview
- 12.8.3 RayBiotech, Inc. Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.8.4 RayBiotech, Inc. Nonspecific Endonuclease Product Portfolio
- 12.8.5 RayBiotech, Inc. Recent Developments
- 12.9 ACROBiosystems Group
- 12.9.1 ACROBiosystems Group Company Information
- 12.9.2 ACROBiosystems Group Business Overview
- 12.9.3 ACROBiosystems Group Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.9.4 ACROBiosystems Group Nonspecific Endonuclease Product Portfolio
- 12.9.5 ACROBiosystems Group Recent Developments
- 12.10 AbMole BioScience
- 12.10.1 AbMole BioScience Company Information
- 12.10.2 AbMole BioScience Business Overview
- 12.10.3 AbMole BioScience Revenue in Nonspecific Endonuclease Business (2021-2026)
- 12.10.4 AbMole BioScience Nonspecific Endonuclease Product Portfolio
- 12.10.5 AbMole BioScience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst